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For the nervous system to translate experience into memory and behavior, lasting structural change at
synapses must occur. This requirement is clearly evident during critical periods of activity-dependent neural
development, and accumulating evidence has established a surprising role for the major histocompatibility
complex class I (MHCI) proteins in this process.During critical periods of activity-dependent neural develop-
ment, early experience sculpts connections to establish adult
circuits via the selection and strengthening of subsets of syn-
apses, combined with weakening and elimination of others.
This selection process can even begin well before sensory expe-
rience. For example, retinal ganglion cell (RGC) axons from the
two eyes are initially intermixed with each other within the lateral
geniculate nucleus (LGN) of the thalamus and later sort from
each other to achieve the eye-specific and topographically
ordered layers of the LGN. Key experiments indicate that appro-
priate correlated patterns of neural activity are required for
segregation (Stellwagen and Shatz, 2002; Torborg and Feller,
2005; Huberman et al., 2008). But just how these patterns of
early activity contribute to synapse remodeling and ultimately
to lasting structural change remain unclear.
An Unbiased Screen Leads to a Surprising Discovery
Several years ago, we initiated studies of LGN synapse remod-
eling motivated by the hypothesis that changes in gene expres-
sion are required to translate initial physiological alterations in
synaptic strength into stable long-term structural changes in
axonal branching and connectivity. Quite unexpectedly, reduc-
tions in neuronal MHCI (class I major histocompatibility com-
plex, also known as HLA in humans) mRNA was discovered in
an unbiased PCR-based differential screen for gene expression
changes in response to blockade of spontaneous neural activity
in the developing fetal cat visual system (Corriveau et al., 1998).
In these experiments, weblocked pre- and postsynaptic activity
by minipump infusions of the sodium channel blocker TTX
during the time of synapse remodeling and formation of eye-
specific layers in the LGN. Such blockades prevent the forma-
tion of the eye-specific layers but allow growth and branching
of LGN RGC axons—though in a now unrestricted manner in
which eye-specific layers fail to form (Sretavan et al., 1988;
Katz and Shatz, 1996). This selective deficit results in mutant
mice that have ‘‘grossly normal’’ brain histology and organiza-
tion and underscores the importance of studying the detailed
patterning of synaptic connections. Indeed, changes in the
details of activity-driven synaptic patterning may underlie
many cognitive and behavioral disorders ranging from autism
to schizophrenia.40 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.Class I MHCs are transmembrane molecules of the Ig super-
family that comprise a large and highly polymorphic gene family
(Maenaka and Jones, 1999; over 50 gene sequences are anno-
tated presently in GenBank), subdivided into ‘‘classical’’ (class
Ia) or ‘‘nonclassical’’ (class Ib; Amadou et al., 1999). The classical
MHCI genes are best known for their roles in cellular-mediated
immunity, where one of their primary functions is to present anti-
genic peptides to cytotoxic T lymphocytes. Loading of foreign
peptides, such as those derived from viral infection, into the
MHCI cleft triggers cell killing consequent to ligation and
signaling by the T cell receptor (TCR) and a required subunit,
CD3 zeta (CD3z; Love et al.; Kane et al., 2000). For cell-surface
expression, the vast majority of MHCI molecules also require
the beta 2 microglobulin (B2m) light chain (Zijlstra et al., 1990).
mRNA for B2m is also present in neurons (Corriveau et al.,
1998). Cell-surface expression of most class Ia MHCs also
requires peptide loading, which occurs in the ER via the TAP1
transporter (e.g., Shastri et al., 2002). Much less is known about
the nonclassical MHCI genes. Expression is more restricted to
specific tissues, they are less polymorphic, and they can be
involved in diverse functions ranging from immune function to
transferrin receptor trafficking (Shawar et al., 1994).
Our identification of MHCI in our unbiased screen implied an
unexpected role for MHC class I in nervous system development
and function. Yet, there had been much controversy over
whether or not neurons express MHCI (mRNA or protein). Until
relatively recently, it had been thought that, with the exception
of damage or viral infection in vivo and/or cytokine stimulation
in vitro, neurons did not express MHCI (Lampson, 1995; Joly
et al., 1991; Neumann et al., 1997; Rall et al., 1995; Oliveira
et al., 2004). These findings have contributed in part to the idea
that the brain is ‘‘immune privileged.’’ Others had argued that
neurons express MHCI only when they are electrically silenced
(Neumann et al., 1997; Rall et al., 1995)—that is, under patholog-
ical conditions. However, it is important to note that in those
experiments, fetal hippocampal neurons were dissociated,
cultured in vitro, and then stimulated to express MHCI with cyto-
kines followed by TTX. In our experiments, we found that MHCI
genes are dynamically regulated in neurons in the healthy, unma-
nipulated brain during development; expression also remains
high in specific regions of adult brain (Corriveau et al., 1998;
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was a clear decrease in mRNAs encodingMHCI in the LGN (Cor-
riveau et al., 1998; Goddard et al., 2007), which is why we had
initially picked up this gene in our unbiased screen. Further,
MHCI mRNA can be downregulated in LGN neurons not only
by blocking spontaneous retinal waves early in development,
but also simply by occluding normal vision in one eye during
early postnatal life. Conversely, following kainate-induced sei-
zures, MHCI mRNA is increased in adult hippocampal neurons
(Corriveau et al., 1998). Together, these findings clearly demon-
strated that neurons in the healthy brain not only normally
express MHCI mRNA but that expression can be regulated by
neural activity and is correlated with times and places of known
synaptic plasticity. Thus, MHCIs are excellent candidates for
linking neural activity to structural changes at synapses and
imply an unexpected role for MHC class I in nervous system
development and function.
The discovery that neurons normally express MHCI mRNA
in vivo without exogenous cytokine stimulation and that expres-
sion is downregulated by activity blockade and upregulated by
seizure is opposite the prior in vitro observations. Many recent
publications using more sensitive amplification methods to
detect both mRNA and protein have demonstrated directly that
neurons in rat, mouse, and cat under normal circumstances
and in pathogen-free animals express MHCI genes- both clas-
sical and nonclassical, as well as B2m (Corriveau et al., 1998;
Huh et al., 2000; McConnell et al., 2009; reviewed in Boulanger
and Shatz, 2004; see Figures 1 and 3 in Boulanger, 2009 [this
issue of Neuron]). Other notable examples include olfactory
receptor neurons in the mouse vomeronasal organ where the
M10 family of nonclassical MHCI genes are expressed (Loconto
et al., 2003; Ishii and Mombaerts, 2008), motoneurons and sub-
stantia nigral neurons (Linda et al., 1999; Thams et al., 2008) and
cortical neurons (Miralve`s et al., 2007). Thus, these in vivo obser-
vations extend and should not be confused with prior in vitro
experimental results.
Indirect Evidence for MHCI Function in Synaptic
Remodeling and Plasticity
Since there are more than 50 MHCI genes in mice, how can one
even begin to examine a requirement for MHCI in the CNS
without knowing exactly which ones might be involved? Immu-
nologists have generated mice with greatly diminished levels of
most MHCI proteins by deleting beta 2 microglobulin (B2m),
a protein required for stable cell surface expression (Dorfman
et al., 1997), or by deleting TAP1, a protein required for loading
of peptide and proper folding of MHC Class I in the endoplasmic
reticulum (Tourne et al., 1996). The initial studies assessing
general roles for MHC class I proteins in synapse remodeling
and plasticity used mice lacking both of these genes (hereafter
referred to as B2m/TAP/ mice). We explicitly searched for
phenotypes associated with abnormalities of activity-dependent
synapse remodeling and plasticity because the original differen-
tial display screen demonstrated that activity blockade downre-
gulatesMHCImRNA in the LGN (Corriveau et al., 1998). Thus, we
reasoned that mice lackingB2m/TAP/might be similar tomice
in which neural activity has been blocked if MHCI proteins play
a critical role in this process.Indeed, these mutant mice have defects in developmental
remodeling of RGC axons in the LGN that resemble deficits
known to result from blocking neural activity. In addition, rules
of hippocampal synaptic plasticity in adult mutant mice are
shifted: in CA1, long-term potentiation (LTP) is enhanced and
long-term depression (LTD) is absent at typical Schaeffer collat-
eral stimulus frequencies (Huh et al., 2000). The phenotypes of
these mice are consistent with the hypothesis that neuronal
MHCI proteins regulate synaptic plasticity in the hippocampus,
as well as structural regression of synapses in the LGN during
development. However, it should be stressed that these conclu-
sions were based on indirect evidence from mice lacking mole-
cules required for the folding and stable cell-surface expression
of many MHCI proteins, rather than loss or gain-of-function
studies of specific MHCI molecules. Clearly, it is now essential
to study mice lacking specific MHCI genes and mice with condi-
tional alleles to examine cell type specificity directly. The field
desperately needs these new lines of mice, as well as other
reagents including antibodies that can recognize individual
MHCI proteins in aldehyde-fixed tissue sections, permitting
ultrastructural localization.
Discovery of Neuronal MHCI Receptors
In the immune system, MHCI family members have very short
intracellular domains not thought to function in intracellular
signaling cascades but instead by interacting with a variety of
receptors during cell-mediated immunity. The most famous
immune cell receptor is the T cell receptor. While our results sug-
gested a role for MHC1 in neuronal plasticity, it was unclear
whether neurons actually expressed MHC receptors. We first
examined if neurons express TCR. Although a TCR transcript
is selectively expressed and developmentally regulated in cor-
tical layer 6 neurons, no transcribed protein could be detected
(Syken and Shatz, 2003), making the TCR an unlikely candidate
MHCI receptor. However CD3z, a component of the TCR needed
for signaling (Kane et al., 2000), is expressed in the LGN tran-
siently during development and is also expressed in the adult
hippocampus (Huh et al., 2000; Baudouin et al., 2008). In mice
lacking CD3z, RGC axons fail to remodel in the LGN and LTP
is enhanced in hippocampus (Huh et al., 2000), implying poten-
tial roles for CD3z-containing MHCI receptor(s) in the CNS.
Another immune receptor thought to bind MHCI is PirB (paired
immunoglobulin-like receptor B), an Ig-like transmembrane
receptor expressed on various types of immune cells. PirB was
discovered in a search for receptors already known to bind
MHCI proteins in the immune system. Studies of B cells in vitro
have shown that MHCI proteins can bind and signal via PirB
(Takai, 2005). Signaling through PirB is dependent on four tyro-
sines located within distinct immunoreceptor tyrosine-based
inhibitory motifs (ITIM) in the intracellular domain and in immune
cells activation of PirB is thought to antagonize integrin andMAP
Kinase signaling cascades (Takai, 2005). Our in situ hybridization
screen revealed that PirB mRNA is highly expressed in certain
regions of mouse CNS, particularly in neurons of cerebral cortex,
olfactory bulb, and granule cells in cerebellum. PirB protein is
located in growth cones and axons of cerebral cortical neurons
in vitro (Syken et al., 2006). Notably, expression of PirB was
not detected in the LGN during the period of activity-dependentNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 41
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Working model (A) for how MHCI might interact with PirB at or near synapses to regulate plasticity. It is proposed that MHCI is located postsynaptically near
glutamate receptors (GLURs) based on immunostaining of hippocampal neuron dendrites and colocalization with PSD-95 shown in (B). The expression of
PirB in axonal growth cones of cortical neurons in vitro (C) suggests a presynaptic location. The intracellular domain of PirB carries four motifs whose phosphor-
ylation (green circles) activates signaling that opposes MAP kinase and integrin cascades. In this model, PirB would signal when bound to MHCI located across
the synapse. Since neural activity regulates MHCI expression levels, PirB could also regulate downstream signaling cascades in an activity-dependent way (B,
modified from Goddard et al., 2007; C, modified from Syken et al., 2006).synapse remodeling, implying that other (possibly CD3 zeta-
containing) MHCI receptors might be present. Indeed, several
labs have recently added other innate immune receptors to the
list of potential neuronal MHCI receptors. For example, Ly49,
a member of the NK (natural killer) family of innate immune
receptors (Zohar et al., 2008), as well as KIR (killer cell immuno-
globulin-like receptor; Bryceson et al., 2005), have been
observed in a variety of CNS neurons.
In the absence of functional PirB, the brains of mutant mice are
grossly normal (Syken et al., 2006). Since PirB mRNA is highly
expressed in cortex (but not LGN), we examined if the ocular
dominance of neurons in primary visual cortex is normal by using
a convenient immediate-early gene induction method for Arc
mRNA to map functionally inputs from each eye to cortical
neurons (Tagawa et al., 2005). While the initial development of
eye input to cortex occurs normally in PirB/ mutant mice,
ocular dominance (OD) plasticity is far from normal. Following
monocular enucleation or monocular visual deprivation in
PirB/ mice during the critical period, OD plasticity is signifi-
cantly enhanced over WT (Syken et al., 2006). Enhanced OD
plasticity is even apparent in adulthood. Once again, these
results stress the need to assess detailed aspects of synaptic
patterning and activity when examining mutant phenotypes.
Importantly, there are very few examples where loss of gene
function results in enhanced plasticity; Nogo receptor (NgR)
mutant mice have a OD plasticity phenotype in adult visual
cortex similar to that of PirB mutant mice (McGee et al., 2005).
Recently, in a most unexpected intersection of research on42 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.axonal regeneration with that on neural plasticity, PirB was
also found to bind Nogo peptide and to regulate growth cone
inhibition on myelin substrates (Atwal et al., 2008), implying
that in some instances PirB and NgR may function in a com-
plex that also includes Nogo peptide. While these results are
intriguing, there are a number of key unanswered questions
including whether growth cone inhibition also requires the partic-
ipation of MHCI proteins. It is also essential to determine if MHCI
mutant mice have phenotypes similar to those of PirB/ and/or
NgR/ mice. Similar neuronal phenotypes would be consistent
with PirB acting as a receptor for neuronal MHCI.
A Working Model for MHCI Function in Healthy Neurons
Similarities in synaptic plasticity phenotypes would lend support
to a working model of neuronal MHCI interacting and signaling
via PirB or other immune receptors expressed on neurons.
Based on observations of MHCI immunostaining localized to
the postsynaptic densities and dendrites of hippocampal neu-
rons in culture (Goddard et al., 2007) and Purkinje cell proximal
dendrites in fixed tissue sections (McConnell et al., 2009), a first
iteration model would suggest that MHCI proteins are located
postsynaptically at or near synapses (Figure 1). MHCI might
then interact across the synapse with immune receptors such
as PirB, located presynaptically based on the observation that
PirB immunostaining is localized near synapsin- positive vesicles
in the growth cones of cortical neurons in culture (Syken et al.,
2006). PirB signaling activates SHP-1,2 phosphatases in neu-
rons (Syken et al., 2006) as well as in immune cells, where PirB
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signaling (Takai, 2005) pathways also involved in long term
synaptic plasticity and OD plasticity (Barco et al., 2005; Hensch,
2004; Taha and Stryker, 2005). MHCI levels are decreased by
activity blockade (Corriveau et al., 1998; Goddard et al., 2007)
and have recently been shown to increase in transgenic mice
expressing a constitutively active form of CREB (Barco et al.,
2005). Thus, it is possible that MHCI acts downstream of
synaptic activity, changes in intracellular Ca2+ and CREB, to
regulate the degree and possibly the sign of synaptic plasticity.
Note that this is not to imply that MHCI molecules are acting as
cell type-specific markers (such as eye-specific markers in the
LGN). Indeed, the normal expression patterns, along with the
phenotypes seen in mutant mice, do not seem consistent with
this idea. However, another not mutually exclusive possibility is
that MHCI molecules could alter trafficking of glutamate recep-
tors by acting in cis as ‘‘chaperones,’’ based on analogy with
certain nonclassical MHCIs and their role in trafficking of trans-
ferrin receptors (Bennett et al., 2000). Immune and neuronal
synapses could have much more in common than thought orig-
inally (Dustin and Colman, 2002). Clearly, the unresolved ques-
tion of where MHCI is located and how it signals in neurons is
a key to understanding the function of this large gene family.
Given examples in the immune system, there could be multiple
modes of signaling in the CNS as well.
MHCI Function and Dysfunction in the CNS
These are early days for newly proposed roles of MHCI in
neurons. Consequently, few labs have considered whether or
how dysregulation of MHCI in the CNS might contribute to
pathology. Since the initial report of MHCI expression and
activity regulation in healthy neurons (Corriveau et al., 1998),
fascinating hints about MHCI function in the context of synapse
plasticity, learning andmemory have come to light. For example,
work from the Kandel lab (Barco et al., 2005) demonstrated that
the same set of MHCI genes known to be expressed in normal
hippocampal neurons (Huh et al., 2000) are also regulated by
CREB. Transgenic mice that express CREB in the hippocampus
under a constitutive (VP16) promoter have highly elevated
mRNAs for H2-K, H2-D, among otherMHCIs, implying that these
may be part of a process whereby LTP is read out. Screens for
dendritic mRNAs in hippocampal neurons have identifiedMHCIs
(Zhong et al., 2006), and MHCI mRNAs are reported to be en-
riched over 4-fold in the FMRP-mRNP complex in dendrites
(Brown et al., 2001). These observations suggest that MHCI
could be synthesized locally in dendrites and regulated by
Fragile X protein. Mouse models of Fragile X have alterations in
hippocampal synaptic plasticity, and OD plasticity in visual
cortex (Huber et al., 2002; Do¨len et al., 2007) related to those
seen in B2m/TAP/ and PirB/ mutant mice. MHCI protein
may be upregulated in cortex of mice expressing the mutant
form of MeCP2 that is known to be involved in the pathogenesis
of Rett syndrome (Miralve`s et al., 2007). It is even conceivable
that altered MHCI expression contributes to synaptic changes
and learning defects in Fragile X and Rett (Moretti et al., 2006;
Chahrour et al., 2008). In this regard, it will be important to deter-
mine whether or not mice lacking MHCI function also have
changes in behaviors related to learning and memory. It isalready known that mice lacking expression of just two of the
more than 50 MHCI molecules (H2-K and H2-D) have enhanced
motor learning on the rotarod, as well as lower threshold LTD in
the cerebellum (McConnell et al., 2009). Given these consider-
ations, it is possible to imagine that altered MHCI function in
the human brain could also result in changes in learning and
memory, some of which could even result in enhancements to
behavior and cognition.
The presence of MHCI in neurons also suggests new ways to
understand and ultimately to treat neurological and psychiatric
disorders including those with known autoimmune components
such asmultiple sclerosis (Bhat and Steinman, 2009 [this issue of
Neuron]). It is also known that exogenous cytokines such as TNF
alpha can alter MHCI cell surface expression on neurons (Neu-
mann et al., 1997), and recent elegant studies have now demon-
strated a normal role for cytokines such as TNF alpha in LTD
(Beattie et al., 2002) and OD plasticity in vivo (Kaneko et al.,
2008). Thus, damage and inflammation might lead to changes
in synaptic plasticity and memory function via dysregulation of
MHCI expression. In a series of three genome-wide studies of
large populations published recently (Shi et al., 2009; Stefansson
et al., 2009; International Schizophrenia Consortium et al., 2009),
polygenic variations on human chromosome 6p22.1 at theMHCI
locus have now been implicated in schizophrenia and bipolar
disorder. While many common gene variants in the MHC region
(both class I and class II) are strongly associated with schizo-
phrenia and bipolar disorder, there was no association with
several non-psychiatric disorders. The authors of the studies
related their observations regarding the MHCI region to the
popular idea that there is a link between schizophrenia and infec-
tion or autoimmunity (Patterson, 2009). While this proposal is
reasonable, a burning question remains: how can early infection
or autoimmune disorders change brain circuits and behavior? If
neuronal MHCI indeed functions at synapses, then the immune
system would have a variety of rather direct ways of communi-
cating with and altering activity-dependent synaptic plasticity
and circuit tuning. Major challenges for the future will be not
only to identify MHCI molecules and receptors in the human
brain, but also to understand how the extraordinary polymor-
phism at the MHCI locus contributes to brain function and
dysfunction.
ACKNOWLEDGMENTS
I wish to thank the many members of my lab both past and present for their
contributions to work cited here, which was supported by NIH R01
EY02858, NIH R01 MH071666, the G. Harold and Leila Y. Mathers Charitable
Foundation and the Dana Foundation.
REFERENCES
Amadou, C., Kumanovics, A., Jones, E.P., Lambracht-Washington, D., Yosh-
ino, M., and Lindahl, K.F. (1999). Themousemajor histocompatibility complex:
some assembly required. Immunol. Rev. 167, 211–221.
Atwal, J.K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, C.J.,
and Tessier-Lavigne, M.T. (2008). PirB is a functional receptor for myelin inhib-
itors of axonal regeneration. Science 322, 967–970.
Barco, A., Patterson, S., Alarcon, J.M., Gromova, P., Mata-Roig, M., Morozov,
A., and Kandel, E.R. (2005). Gene expression profiling of facilitated L-LTP inNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 43
Neuron
PerspectiveVP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and
its synaptic capture. Neuron 48, 123–137.
Baudouin, S.J., Angibaud, J., Loussouarn, G., Bonnamain, V., Matsuura, A.,
Kinebuchi, M., Naveilhan, P., and Boudin, H. (2008). The signaling adaptor
protein CD3zeta is a negative regulator of dendrite development in young
neurons. Mol. Biol. Cell 19, 2444–2456.
Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von
Zastrow, M., Beattie, M.S., and Malenka, R.C. (2002). Control of synaptic
strength by glial TNFalpha. Science 295, 2282–2285.
Bennett, M.J., Lebron, J.A., and Bjorkman, P.J. (2000). Crystal structure of the
hereditary hemochromatosisprotein HFE complexed with the transferrin
receptor. Nature 403, 46–53.
Bhat, R., and Steinman, L. (2009). Innate and adaptive autoimmunity directed
to the central nervous system. Neuron 64, this issue, 123–132.
Brown, V., Jin, P., Ceman, S., Darnell, J.C., O’Donnell, W.T., Tenenbaum, S.A.,
Jin, X., Feng, Y., Wilkinson, K.D., Keene, J.D., et al. (2001). Microarray identi-
fication of FMRP-associated brain mRNAs and altered mRNA translational
profiles in fragile X syndrome. Cell 107, 477–487.
Boulanger, L.M. (2009). Immune proteins in brain development and synaptic
plasticity. Neuron 64, this issue, 93–109.
Boulanger, L.M., and Shatz, C.J. (2004). Immune signaling in neural develop-
ment, synaptic plasticity, and disease. Nat. Rev. Neurosci. 5, 521–531.
Bryceson, Y.T., Foster, J.A., Kuppusamy, S.P., Herkenham, M., and Long,
E.O. (2005). Expression of a killer cell receptor-like gene in plastic regions of
the central nervous system. J. Neuroimmunol. 161, 177–182.
Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., and Zoghbi,
H.Y. (2008). MeCP2, a key contributor to neurological disease, activates and
represses transcription. Science 320, 1224–1229.
Corriveau, R.A., Huh, G.S., and Shatz, C.J. (1998). Regulation of Class I MHC
gene expression in the developing and mature CNS by neural activity. Neuron
21, 505–520.
Do¨len, G., Osterweil, E., Rao, B.S., Smith, G.B., Auerbach, B.D., Chattarji, S.,
and Bear, M.F. (2007). Correction of fragile X syndrome in mice. Neuron 56,
955–962.
Dorfman, J.R., Zerrahn, J., Coles, M.C., and Raulet, D.H. (1997). The basis for
self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.
J. Immunol. 159, 5219–5225.
Dustin, M.L., and Colman, D.R. (2002). Neural and immunological synaptic
relations. Science 298, 785–789.
Goddard, C.A., Butts, D., and Shatz, C.J. (2007). Regulation of CNS synapses
by neuronal MHC Class I. Proc. Natl. Acad. Sci. USA 104, 6828–6833.
Hensch, T.K. (2004). Critical period regulation. Annu. Rev. Neurosci. 27,
549–579.
Huber, K.M., Gallagher, S.M., Warren, S.T., and Bear, M.F. (2002). Altered
synaptic plasticity in a mouse model of fragile X mental retardation. Proc.
Natl. Acad. Sci. USA 99, 7746–7750.
Huberman, A.D., Feller, M.B., and Chapman, B. (2008). Mechanisms under-
lying development of visual maps and receptive fields. Annu. Rev. Neurosci.
31, 479–509.
Huh, G.S., Boulanger, L.M., Du, H., Riquelme, P., Brotz, T.M., and Shatz, C.J.
(2000). Functional requirement for Class I MHC in CNS development and plas-
ticity. Science 290, 2155–2159.
International Schizophrenia Consortium, Purcell, S.M., Wray, N.R., Stone, J.L.,
Visscher, P.M., O’Donovan, M.C., Sullivan, P.F., and Sklar, P. (2009). Common
polygenic variation contributes to risk of schizophrenia and bipolar disorder.
Nature 460, 748–752.
Ishii, T., and Mombaerts, P. (2008). Expression of nonclassical class I major
histocompatibility genes defines a tripartite organization of the mouse vomer-
onasal system. J. Neurosci. 28, 2332–2341.44 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.Joly, E., Mucke, L., and Oldstone, M.B.A. (1991). Viral persistence in neurons
explained by lack of major histocompatibility class I expression. Science 253,
1283–1285.
Katz, L.C., and Shatz, C.J. (1996). Synaptic activity and the construction of
cortical circuits. Science 274, 1133–1138.
Kane, L.P., Lin, J., and Weiss, A. (2000). Signal transduction by the TCR for
antigen. Curr. Opin. Immunol. 12, 242–249.
Kaneko, M., Stellwagen, D., Malenka, R.C., and Stryker, M.P. (2008). Tumor
necrosis factor-alpha mediates one component of competitive, experience-
dependent plasticity in developing visual cortex. Neuron 58, 673–680.
Lampson, L.A. (1995). Interpreting MHC class I expression and class I/class II
reciprocity in the CNS: reconciling divergent findings. Microsc. Res. Tech. 32,
267–285.
Linda, H., Hammarberg, H., Piehl, F., Khandemi, M., and Olsson, T. (1999).
Expression of MHC Class I heavy chain and B2 microglobulin in rat brainstem
motoneurons and nigral dopaminergic neurons. J. Neuroimmunol. 101, 76–86.
Loconto, J., Papes, F., Chang, E., Stowers, L., Jones, E.P., Takada, T., Kuma´-
novics, A., Fishcer Lindahl, K., and Dulac, C. (2003). Functional expression of
murine V2R pheromone receptors involves selective association with the M10
and M1 families of MHC class Ib molecules. Cell 112, 607–618.
Maenaka, K., and Jones, E.Y. (1999). MHC superfamily structure and the
immune system. Curr. Opin. Struct. Biol. 9, 745–753.
McConnell, M.J., Huang, Y.H., Datwani, A., and Shatz, C.J. (2009). H2-Kb and
H2-Db regulate cerebellar long term depression and limit motor learning. Proc.
Natl. Acad. Sci. USA 106, 6784–6789.
McGee, A.W., Yang, Y., Fischer, Q.S., Daw, N.W., and Strittmatter, S.M.
(2005). Experience-driven plasticity of visual cortex limited by myelin and
Nogo receptor. Science 309, 2222–2226.
Miralve`s, J., Magdeleine, E., Kaddoum, L., Brun, H., Peries, S., and Joly, E.
(2007). High levels of MeCP2 depress MHC class I expression in neuronal
cells. PLoS ONE 2, e1354.
Moretti, P., Levenson, J.M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B.,
Armstrong, D., Arancio, O., Sweatt, J.D., and Zoghbi, H.Y. (2006). Learning
and memory and synaptic plasticity are impaired in a mouse model of Rett
syndrome. J. Neurosci. 26, 319–327.
Neumann, H., Schmidt, H., Cavalie, A., Jenne, D., and Wekerle, H. (1997).
Major histocompatibility complex (MHC) class I gene expression in single
neurons of the central nervous system: differential regulation by interferon
(IFN)-gamma and tumor necrosis factor (TNF)-alpha. J. Exp. Med. 185,
305–316.
Oliveira, A.L., Thams, S., Lidman, O., Piehl, F., Ho¨kfelt, T., Ka¨rre, K., Linda˚, H.,
and Cullheim, S. (2004). A role for MHC class I molecules in synaptic plasticity
and regeneration of neurons after axotomy. Proc. Natl. Acad. Sci. USA 101,
17843–17848.
Patterson, P.H. (2009). Immune involvement in schizophrenia and autism:
etiology, pathology and animal models. Behav. Brain Res. 204, 313–321.
Rall, G.F., Mucke, L., and Oldstone, M.B. (1995). Consequences of cytotoxic T
lymphocyte interaction with major histocompatibility complex class I-express-
ing neurons in vivo. J. Exp. Med. 182, 1201–1212.
Shi, J., Levinson, D.F., Duan, J., Sanders, A.R., Zheng, Y., Pe’er, I., Dudbridge,
F., Holmans, P.A., Whittemore, A.S., Mowry, B.J., et al. (2009). Common vari-
ants on chromosome 6p22.1 are associated with schizophrenia. Nature 460,
753–757.
Shawar, S.M., Vyas, J.M., Rodgers, J.R., and Rich, R.R. (1994). Antigen
presentation by major histocompatibility complex class I-b molecules. Annu.
Rev. Immunol. 12, 839–880.
Shastri, N., Schwab, S., and Serwold, T. (2002). Producing nature’s gene
chips: the generation of peptides for display by MHC Class I molecules.
Annu. Rev. Immunol. 20, 463–493.
Stellwagen, D., and Shatz, C.J. (2002). An instructive role for retinal waves in
the development of retinogeniculate connectivity. Neuron 33, 357–367.
Neuron
PerspectiveSyken, J., and Shatz, C.J. (2003). Expression of T Cell Receptor Beta Locus in
CNS neurons. Proc. Natl. Acad. Sci. USA 100, 13048–13053.
Syken, J., Grandpre, T., Kanold, P.O., and Shatz, C.J. (2006). PIRB restricts
ocular dominance plasticity in visual cortex. Science 313, 1795–1800.
Sretavan, D.W., Shatz, C.J., and Stryker, M.P. (1988). Modification of retinal
ganglion cell axon morphology by prenatal infusion of tetrodotoxin. Nature
336, 468–471.
Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S.,
Rujescu, D., Werge, T., Pietila¨inen, O.P., Mors, O., Mortensen, P.B., et al.
(2009). Common variants conferring risk of schizophrenia. Nature 460,
744–747.
Tagawa, Y., Kanold, P.O., Majdan, M., and Shatz, C.J. (2005). Multiple periods
of functional ocular dominance plasticity in mouse visual cortex. Nat. Neuro-
sci. 3, 380–388.
Taha, S.A., and Stryker, M.P. (2005). Molecular substrates of plasticity in the
developing visual cortex. Prog. Brain Res. 147, 103–114.
Takai, T. (2005). Paired immunoglobulin-like receptors and their MHC class I
recognition. Immunology 115, 433–440.Thams, S., Oliveira, A., and Cullheim, S. (2008). MHC class I expression and
synaptic plasticity after nerve lesion. Brain Res. Brain Res. Rev. 57, 265–269.
Torborg, C.L., and Feller, M.B. (2005). Spontaneous patterned retinal activity
and the refinement of retinal projections. Prog. Neurobiol. 76, 213–235.
Tourne, S., van Santen, H.M., van Roon, M., Berns, A., Benoist, C., Mathis, D.,
and Ploegh, H. (1996). Biosynthesis of major histocompatibility complex mole-
cules and generation of T cells in TAP1 double-mutant mice. Proc. Natl. Acad.
Sci. USA 93, 1464–1469.
Zohar, O., Reiter, Y., Bennink, J.R., Lev, A., Cavallaro, S., Paratore, S., Pick,
C.G., Brooker, G., and Yewdell, J.W. (2008). Cutting edge: MHC class
I-Ly49 interaction regulates neuronal function. J. Immunol. 180, 6447–6451.
Zhong, J., Zhang, T., and Bloch, L.M. (2006). Dendritic mRNAs encode diver-
sified functionalities in hippocampal pyramidal neurons. BMC Neurosci. 7,
17–31.
Zijlstra, M., Bix, M., Simister, N.E., Loring, J.M., Raulet, D.H., and Jaenish, R.
(1990). Beta 2-microglobulin deficient mice lack CD4–8+ cytolytic T cells.
Nature 344, 742–746.Neuron 64, October 15, 2009 ª2009 Elsevier Inc. 45
